Today, Good AI is excited to announce our Series B investment in Bit Bio, a synthetic biology company that is coding human cells to precision engineer the next generation of medicine.
Share this post
Meet BitBio, the company reprogramming the…
Share this post
Today, Good AI is excited to announce our Series B investment in Bit Bio, a synthetic biology company that is coding human cells to precision engineer the next generation of medicine.